ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 81

Elevated Peripheral Blood Leukocyte Inflammatory Gene Expression in Radiographic Progressors with Symptomatic Knee Osteoarthritis: NYU and OAI Cohorts

Mukundan Attur1, Alexander Statnikov2, Svetlana Krasnokutsky Samuels1, Virginia B. Kraus3, Joanne Jordan4, Braxton D. Mitchell5, Michelle Yau6, Jyoti Patel1, Constantin F. Aliferis2, Marc C. Hochberg7, Jonathan Samuels1 and Steven B. Abramson8, 1Rheumatology, NYU Langone Medical Center, New York, NY, 2Center for Health Informatics and Bioinformatics, NYU Langone Medical Center, New York, NY, 3Medicine/Rheumatology, Duke University Medical Center, Durham, NC, 4Thurston Arthritis Research Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 5Departments of Medicine and Epidemiology & Public Health, University of Maryland School of Medicine, Baltimore, MD, 6Epidemiology and Public Health, University of Maryland, Baltimore,, MD, 7Medicine, University of Maryland School of Medicine, Baltimore, MD, 8Dept of Rheumatology/Medicine, NYU Langone Medical Center, New York, NY

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Biomarkers, cyclooxygenase, interleukins (IL), osteoarthritis and tumor necrosis factor (TNF)

  • Tweet
  • Email
  • Print
Session Information

Title: Genetics, Genomics and Proteomics I

Session Type: Abstract Submissions (ACR)

Background/Purpose: We and others have demonstrated low grade inflammation exists in OA joint tissues, where it may contribute to disease pathogenesis. In the current studies we assessed whether inflammatory events occurring within joint tissues were reported in the peripheral blood leukocytes (PBLs) of patients with symptomatic knee OA (SKOA).

Methods: PBL inflammatory gene expression (IL-1, TNFα, COX-2) was assessed in two independent cohorts of patients with SKOA, and a cohort of healthy control subjects: 1) 111 patients with tibiofemoral medial OA and 21 healthy volunteers from the NYUHJD Cohort, and 2) 200 patients from the OAI progression cohort who had “high quality radiographs”, at both baseline and 24 months, and had KL2 or 3 in the signal knee at baseline. Radiographic progression was defined as narrowing of medial joint space width (JSW) in the signal knee between baseline and 24-months in each cohort. Fast progressors were defined as subjects who had JSN >0.5mm over 24 months. For measuring predictive performance, we used the area under the curve (AUC) of a receiver operating characteristics (ROC). OAI SKOA subjects were dichotomized as radiographic non-progressors (JSN <0.0 mm) and progressors (JSN>0.0mm) for association studies.

Results: Elevated PBL expression of IL-1, TNFα or COX-2 at baseline identified SKOA patients who were “fast progressors” (mean JSN 0= 0.71, 0.75 and 0.71 mm / 24 months, respectively) compared to patients with levels below the median (Table 1). In a multivariable model, anthropometric traits alone (BMI, gender, age) did not predict progression, whereas addition of PBL gene expressions improved prediction of fast progressors (JSN>0.5mm). We next examined inflammatory gene expression in PBLs of radiographic progressors in the OAI cohort. Similar to the NYUHJD cohort, elevated expression of IL-1β, TNFα and COX-2 mRNA at baseline distinguished radiographic progressors from non-progressors (Table 2).

Conclusion: We identified, and confirmed in two cohorts, increased inflammatory gene expression (IL-1, TNFα or COX-2) by PBLs that predict radiographic progression in patients with SKOA. The data indicate that inflammatory events within joint tissues of patients with SKOA are reported in the peripheral blood. These PBL transcriptome signals of local joint inflammation merit further study as potential biomarkers for OA disease progression.



Disclosure:

M. Attur,

Patent,

9;

A. Statnikov,
None;

S. Krasnokutsky Samuels,
None;

V. B. Kraus,

NIAMS-NIH,

2;

J. Jordan,
None;

B. D. Mitchell,
None;

M. Yau,
None;

J. Patel,
None;

C. F. Aliferis,
None;

M. C. Hochberg,

NIH,

2;

J. Samuels,
None;

S. B. Abramson,

NIAMS-NIH,

2,

Patent,

9.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/elevated-peripheral-blood-leukocyte-inflammatory-gene-expression-in-radiographic-progressors-with-symptomatic-knee-osteoarthritis-nyu-and-oai-cohorts/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology